Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Healwell AI Inc. (AIDX.TO)
CAD0.70
+0.00 (+0.00%)
CA TSX Healthcare Medical - Care Facilities
Address
4881 Yonge Street M2N 5X3
Toronto, ON, CA
Toronto, ON, CA
CEO
Aaron Leibtag
Website
healwell.ai
IPO
2021-01-06
ISIN CA42249X1006
Also trades on
Other OTC · HWAIF (USD)
Stuttgart Stock Exchange · 6H90.SG (EUR)
Toronto Stock Exchange · AIDX.TO (CAD)
Description
Healwell AI Inc., a Toronto-based healthcare technology firm established in 2012, specializes in leveraging artificial intelligence and data science to advance preventative medical care. The company develops an AI-powered platform designed to assist healthcare providers with crucial decision-making. They maintain a significant strategic partnership with WELL Health Technologies Corp., focusing on accelerating the expansion and innovation of AI-driven healthcare solutions. Prior to its current name, adopted in October 2023, the organization was known as MCI Onehealth Technologies Inc.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CAD0.70
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
369.7K
Beta
-0.96
Float Shares
32.74M
Free Float %
11.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.29% | -9.18% | +8.54% | +30.88% | -27.05% | +5.95% | -41.06% | +423.53% | -68.10% | -80.31% | -80.31% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.70
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 7 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
0.40
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+166.4% ★ Q1'26: +135.7% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+0.0% Q1'26: +70.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-38.6% Q1'26: +14.5% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%-28.4% Q1'26: -17.5% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%-15.4% Q1'26: -12.5% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+84.8% Q1'26: +71.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×-6.82× Q1'26: -30.16× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 5 EPS Ana. |
Dec 2027 9 Rev. Ana. 8 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
38.57M
est: 36.60M (+5.4%)
|
47.82M
est: 48.52M (-1.4%)
|
10.42M
est: 53.55M (-80.5%)
|
7.32M
est: 13.58M (-46.1%)
|
38.97M
est: 38.17M (+2.1%)
|
103.80M
est: 102.56M (+1.2%)
|
136.72M
132.71M – 143.24M
+33.3% YoY
|
158.04M
151.14M – 167.65M
+15.6% YoY
|
205.40M
197.80M – 216.63M
+30.0% YoY
|
246.60M
237.47M – 260.09M
+20.1% YoY
|
297.60M
286.59M – 313.87M
+20.7% YoY
|
| EBITDA |
2.11M
est: -19.45M (+110.9%)
|
-11.44M
est: -25.78M (+55.6%)
|
-13.94M
est: -28.46M (+51.0%)
|
-16.11M
est: -7.70M (-109.3%)
|
-18.42M
est: -21.63M (+14.8%)
|
-12.62M
est: -58.12M (+78.3%)
|
-77.48M
-81.17M – -75.21M
-33.3% YoY
|
-89.56M
-95.00M – -85.65M
-15.6% YoY
|
-116.40M
-122.77M – -112.09M
-30.0% YoY
|
-139.75M
-147.39M – -134.58M
-20.1% YoY
|
-168.65M
-177.87M – -162.41M
-20.7% YoY
|
| EBIT |
-842.0K
est: -22.04M (+96.2%)
|
-15.83M
est: -29.22M (+45.8%)
|
-16.46M
est: -32.25M (+49.0%)
|
-17.59M
est: -8.89M (-97.8%)
|
-25.67M
est: -24.99M (-2.7%)
|
-29.53M
est: -67.15M (+56.0%)
|
-89.51M
-93.78M – -86.89M
-33.3% YoY
|
-103.48M
-109.76M – -98.96M
-15.6% YoY
|
-134.48M
-141.84M – -129.51M
-30.0% YoY
|
-161.46M
-170.29M – -155.48M
-20.1% YoY
|
-194.85M
-205.51M – -187.64M
-20.7% YoY
|
| Net Income |
-1.03M
est: 1.36M (-175.9%)
|
-15.67M
est: -42.02M (+62.7%)
|
-21.09M
est: -54.22M (+61.1%)
|
-31.60M
est: -49.40M (+36.0%)
|
-26.29M
est: -40.88M (+35.7%)
|
-46.94M
est: -45.62M (-2.9%)
|
-27.13M
-31.18M – -7.79M
+40.5% YoY
|
-9.71M
-17.26M – -2.16M
+64.2% YoY
|
-10.14M
-10.73M – -9.54M
-4.4% YoY
|
-2.51M
-2.68M – -2.38M
+75.3% YoY
|
2.51M
2.38M – 2.68M
+200.0% YoY
|
| SGA |
13.74M
est: 38.18M (-64.0%)
|
31.30M
est: 50.61M (-38.2%)
|
12.88M
est: 55.86M (-76.9%)
|
13.26M
est: 14.60M (-9.2%)
|
45.08M
est: 41.03M (+9.9%)
|
53.50M
est: 110.26M (-51.5%)
|
146.98M
142.67M – 153.99M
+33.3% YoY
|
169.90M
162.48M – 180.23M
+15.6% YoY
|
220.81M
212.64M – 232.89M
+30.0% YoY
|
265.11M
255.29M – 279.60M
+20.1% YoY
|
319.93M
308.09M – 337.43M
+20.7% YoY
|
| EPS |
-0.01
est: 0.01 (-225.0%)
|
-0.33
est: -0.31 (-6.5%)
|
-0.42
est: -0.40 (-5.0%)
|
-0.55
est: -0.19 (-182.2%)
|
-0.19
est: -0.16 (-20.0%)
|
-0.19
est: -0.18 (-5.6%)
|
-0.08
-0.12 – -0.03
+56.8% YoY
|
-0.04
-0.07 – -0.01
+50.2% YoY
|
-0.04
-0.04 – -0.04
-3.2% YoY
|
-0.01
-0.01 – -0.01
+75.0% YoY
|
0.01
0.01 – 0.01
+200.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
8.10M
OE per share TTM
0.02
Owner's Yield
2.87%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
23.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-84.4K
Shares Outstanding
293.32M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Madeline D. Walker | President of MCI Medical | 627.9K | female |
| Alexander Julian Dobranowski | Founder, President, MD & Director | 350.0K | — |
| Anthony Lam | Chief Financial Officer | 302.3K | male |
| Aaron Leibtag | Pentavere Research Group -CEO | 250.0K | — |
| Blake Corbet | Senior Vice President of Corporate Development | 225.0K | male |
| Nolan Reeds | Vice President of Marketing & Communications | — | — |
| Sacha Gera | Chief Operating Officer | — | male |
| Brad Porter | Chief Commercial Officer & Director | — | male |
| James Lee | Chief Executive Officer | — | male |
| Mark Findlay | Senior Vice President of Sales & Marketing for Canada | — | male |
| Noah Crampton | Chief Executive Officer of Mutuo Health Solutions | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AIDX.TO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
